Stoke Therapeutics Short Interest Ratio and Short Volume

Short interest is the volume of Stoke Therapeutics shares that have been sold short but have not yet been closed out or covered. As of February 12th, investors have sold 3,370,000 shares of STOK short. 17.91% of Stoke Therapeutics' shares are currently sold short. View details.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Stoke Therapeutics currently has a short interest ratio of 21.0.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 17.91% of Stoke Therapeutics' floating shares are currently sold short.

Stoke Therapeutics saw a drop in short interest in the month of February. As of February 12th, there was short interest totaling 3,370,000 shares, a drop of 3.2% from the previous total of 3,480,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Stoke Therapeutics currently has issued a total of 33,470,000 shares. Some of Stoke Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Stoke Therapeutics currently has a public float of 18,820,000 shares.

17.91% of Stoke Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Stoke Therapeutics: Ionis Pharmaceuticals, Inc. (5.97%), ACADIA Pharmaceuticals Inc. (0.00%), United Therapeutics Co. (4.02%), Schrödinger, Inc. (6.47%), Sarepta Therapeutics, Inc. (0.00%), GW Pharmaceuticals plc (0.00%), Evotec SE (0.00%), Allakos Inc. (9.06%), Atea Pharmaceuticals, Inc. (3.65%), and Maravai LifeSciences Holdings, Inc. (3.64%).

As of the most recent reporting period, the following stocks had the largest short interest positions: ViacomCBS Inc. ($6.50 billion), Aon Plc ($5.58 billion), Charter Communications, Inc. ($5.30 billion), Analog Devices, Inc. ($4.97 billion), Snap Inc. ($3.80 billion), Futu Holdings Limited ($2.84 billion), Airbnb, Inc. ($2.40 billion), Discovery, Inc. ($2.35 billion), Snowflake Inc. ($2.07 billion), and The Kroger Co. ($2.00 billion). View all of the most shorted stocks.

Short selling STOK is an investing strategy that aims to generate trading profit from Stoke Therapeutics as its price is falling. Stoke Therapeutics' stock is trading down $1.14 today. To short Stoke Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Stoke Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Stoke Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of STOK, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including STOK, twice per month. The most recent reporting period available is February, 12 2021.